Navigation Links
Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services
Date:8/18/2008

BOSTON, Aug. 18 /PRNewswire-USNewswire/ -- Boston University and Aubrey Milunsky, MB.B.Ch, D.Sc., President of the Center for Human Genetics, Inc. ("CHG") and Director of the Center for Human Genetics of Boston University, announced that CHG will no longer offer testing services covered by patents licensed to Athena Diagnostics, Inc.

These patented tests include tests relating to: CADASIL, hearing loss related to A1555G or Connexin 26 mutations, developmental disorders caused by mutation of the ARX gene, Duchene's muscular dystrophy, myotonic dystrophy (DM1), Freidreich's Ataxia (FRDA), hereditary neuropathy with pressure palsies, polycystic kidney disease, spinal muscular atrophy (SMN1), spinocerebellar ataxia (SCA1, 2, 3, 6, 7 and 8) and tuberous sclerosis (type 2). This decision follows a negotiated settlement agreement with Athena, which had brought the issue to the attention of the University and CHG. Athena has made no objection to, and the settlement does not affect any non-commercial research activities at Boston University.

Much of the technology underlying these testing services was discovered by academic scientists, patented by their respective universities, and licensed to Athena Diagnostics for commercial development of diagnostic testing services. Boston University respects intellectual property rights.

The Center for Human Genetics, Inc. has advised its clients that it will henceforth either forward any future request for an Athena-licensed testing service to Athena for processing, or notify the requesting client that it may procure the services directly from Athena.

Massachusetts-based Athena makes available a wide range of more than 200 testing services, for a variety of neurological, endocrine, and renal disorders with genetic or other etiologies.


'/>"/>
SOURCE Boston University
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , Jan. 18, 2017 The Global ... understanding and access to partnering deals and agreements entered ... Trends in partnering deals - Top deals by value ... of development, technology type The report provides understanding ... into by the world,s leading healthcare companies. The ...
(Date:1/19/2017)... Jan. 18, 2017 The Academy of ... Drug Administration (FDA) for its release today of ... health decision makers can proactively share clinical and ... well as emerging therapies awaiting FDA approval. ... recommendations that AMCP developed during two multi-stakeholder meetings ...
(Date:1/18/2017)... PUNE, India , January 18, 2017 ... "Breast Imaging Technologies Market by Type: Global Opportunity Analysis and ... market size was valued at $2,544 million in 2015 and ... a CAGR of 8.4% from 2016 to 2022. ... together accounted for over three-fourths market share in 2015. Ionizing ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... Ultimate ... in 2017 who are passionate about making a difference in the lives of ... in Tampa, UMA, a nonprofit healthcare educational institution, has more than 30,000 alumni ...
(Date:1/19/2017)... ... January 19, 2017 , ... Sam & Associates Insurance ... commercial and residential clients in the California Bay Area, is launching a charity drive ... the region. , Heart disease is the primary killer of adult men and women ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... Tribble Insurance ... to the eastern Virginia region, is inaugurating a charity event to honor Chad Phillip ... While on duty last year, Chad Phillip Dermyer and his fellow officers were conducting ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... St. Catherine’s ... Center. , Siena Center is a skilled nursing facility on the grounds of the ... semiprivate rooms. It recently was voted the best nursing home in Mississippi for the ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... Spring Create Real Impact contest from Impact Teen Drivers and California Casualty. Entries ... . , Educational grants totaling $15,000 will be awarded for the best ...
Breaking Medicine News(10 mins):